| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| IMTXImmatics N.V. | 1.33B | 9.92 | 70.86 | 188.6% | -136.72% | -27.81% | 0.03 | |
| CTMXCytomX Therapeutics, Inc. | 720.1M | 4.25 | 11.18 | 36.45% | 24.66% | 26.09% | ||
| IOVAIovance Biotherapeutics, Inc. | 881.27M | 2.22 | -1.73 | 136.99% | -158.78% | -56.62% | 0.08 | |
| REPLReplimune Group, Inc. | 572.64M | 7.30 | -2.38 | -117.82% | 0.18 | |||
| NKTRNektar Therapeutics | 719.28M | 35.36 | -4.07 | 9.22% | -192.87% | -141.9% | 1.69 | |
| IMNMImmunome, Inc. | 2.52B | 22.85 | -4.57 | -35.5% | -23.01% | -84.4% | 0.03 | |
| IBRXImmunityBio, Inc. | 3.89B | 3.95 | -6.37 | 22.71% | -422.28% | |||
| NRIXNurix Therapeutics, Inc. | 1.91B | 18.86 | -6.55 | -29.15% | -292.5% | -65.76% | 0.05 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.91M | 2.51M | 21.91M | 33.5M | 27.76M | 24.51M | 43.15M | 38.84M | 39.81M | 34.88M |
| Revenue Growth % | 0.46% | 0.32% | 7.73% | 0.53% | -0.17% | -0.12% | 0.76% | -0.1% | 0.02% | -0.12% |
| Cost of Goods Sold | 16.18M | 18.42M | 34.13M | 47.81M | 49.64M | 57.33M | 86.27M | 9.95M | 10.5M | 21.92M |
| COGS % of Revenue | 8.49% | 7.34% | 1.56% | 1.43% | 1.79% | 2.34% | 2% | 0.26% | 0.26% | 0.63% |
| Gross Profit | -14.28M | -15.91M | -12.21M | -14.31M | -21.88M | -32.82M | -43.12M | 28.88M | 29.31M | 12.96M |
| Gross Margin % | -7.49% | -6.34% | -0.56% | -0.43% | -0.79% | -1.34% | -1% | 0.74% | 0.74% | 0.37% |
| Gross Profit Growth % | -0.39% | -0.11% | 0.23% | -0.17% | -0.53% | -0.5% | -0.31% | 1.67% | 0.01% | -0.56% |
| Operating Expenses | 8.84M | 11.97M | 23.09M | 25.62M | 30.41M | 29.29M | 35.93M | 178.34M | 171.11M | 275.58M |
| OpEx % of Revenue | 4.64% | 4.77% | 1.05% | 0.76% | 1.1% | 1.19% | 0.83% | 4.59% | 4.3% | 7.9% |
| Selling, General & Admin | 937K | 4.83M | 14.32M | 25.62M | 28.8M | 29.29M | 35.93M | 48.75M | 54.2M | 79.96M |
| SG&A % of Revenue | 0.49% | 1.92% | 0.65% | 0.76% | 1.04% | 1.19% | 0.83% | 1.26% | 1.36% | 2.29% |
| Research & Development | 16.18M | 18.42M | 34.13M | 52.17M | 53.65M | 62.25M | 94.44M | 148.23M | 132.75M | 229.9M |
| R&D % of Revenue | 8.49% | 7.34% | 1.56% | 1.56% | 1.93% | 2.54% | 2.19% | 3.82% | 3.33% | 6.59% |
| Other Operating Expenses | -8.28M | -11.28M | -25.36M | -52.17M | -52.05M | -62.25M | -94.44M | -18.64M | -15.85M | -34.28M |
| Operating Income | -23.11M | -27.88M | -35.3M | -39.93M | -52.29M | -62.11M | -79.05M | -149.46M | -141.8M | -262.63M |
| Operating Margin % | -12.13% | -11.11% | -1.61% | -1.19% | -1.88% | -2.53% | -1.83% | -3.85% | -3.56% | -7.53% |
| Operating Income Growth % | -0.33% | -0.21% | -0.27% | -0.13% | -0.31% | -0.19% | -0.27% | -0.89% | 0.05% | -0.85% |
| EBITDA | -22.92M | -27.65M | -34.98M | -39.27M | -51.28M | -60.93M | -77.75M | -148.26M | -139.5M | -260.24M |
| EBITDA Margin % | -12.03% | -11.01% | -1.6% | -1.17% | -1.85% | -2.49% | -1.8% | -3.82% | -3.5% | -7.46% |
| EBITDA Growth % | -0.34% | -0.21% | -0.27% | -0.12% | -0.31% | -0.19% | -0.28% | -0.91% | 0.06% | -0.87% |
| D&A (Non-Cash Add-back) | 193K | 234K | 318K | 658.17K | 1.01M | 1.18M | 1.3M | 1.2M | 2.3M | 2.39M |
| EBIT | -18.69M | -26.39M | -34.26M | -39.93M | -50.69M | -62.11M | -79.05M | -149.46M | -141.8M | -262.63M |
| Net Interest Income | -158.53K | 92.55K | 1.11M | 2.13M | 1.89M | 300K | -129K | 2.72M | 14.51M | 30.79M |
| Interest Income | 54.66K | 92.55K | 1.33M | 2.13M | 1.89M | 300K | 0 | 2.72M | 14.51M | 30.79M |
| Interest Expense | 213.19K | 0 | 227.94K | 0 | 0 | 0 | 129K | 0 | 0 | 0 |
| Other Income/Expense | -145K | -19.56M | -29.22M | 15.4M | 3.3M | -7.48M | 20.56M | 27.83M | 4.35M | 62.64M |
| Pretax Income | -23.26M | -47.44M | -64.53M | -24.53M | -48.99M | -69.59M | -58.49M | -121.63M | -137.45M | -199.99M |
| Pretax Margin % | -12.21% | -18.9% | -2.94% | -0.73% | -1.77% | -2.84% | -1.36% | -3.13% | -3.45% | -5.73% |
| Income Tax | 0 | 0 | 249K | 178.94K | 172.95K | 411.75K | 209.99K | 895.61K | 2.89M | 7.87M |
| Effective Tax Rate % | 1% | 1% | 1% | 1.01% | 1% | 1.01% | 1% | 1.01% | 1.02% | 1.04% |
| Net Income | -23.26M | -47.44M | -64.77M | -24.71M | -49.17M | -70M | -58.7M | -122.52M | -140.34M | -207.85M |
| Net Margin % | -12.21% | -18.9% | -2.96% | -0.74% | -1.77% | -2.86% | -1.36% | -3.15% | -3.53% | -5.96% |
| Net Income Growth % | -0.34% | -1.04% | -0.37% | 0.62% | -0.99% | -0.42% | 0.16% | -1.09% | -0.15% | -0.48% |
| Net Income (Continuing) | -23.26M | -47.44M | -64.77M | -24.71M | -49.17M | -70M | -58.7M | -122.52M | -140.34M | -207.85M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.65 | -3.75 | -3.81 | -1.28 | -2.28 | -2.92 | -1.73 | -2.92 | -3.00 | -3.35 |
| EPS Growth % | -0.2% | -1.27% | -0.02% | 0.66% | -0.78% | -0.28% | 0.41% | -0.69% | -0.03% | -0.12% |
| EPS (Basic) | -1.65 | -3.75 | -3.81 | -1.28 | -2.28 | -2.92 | -1.73 | -2.92 | -3.00 | -3.35 |
| Diluted Shares Outstanding | 15.41M | 13.23M | 19.2M | 22.29M | 24.22M | 29.26M | 38.64M | 44.92M | 51.61M | 64.22M |
| Basic Shares Outstanding | 15.41M | 13.23M | 19.2M | 22.29M | 24.22M | 29.26M | 38.64M | 44.92M | 51.61M | 64.22M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 37.74M | 74.8M | 225.7M | 223.79M | 247.37M | 217.99M | 424.18M | 306.44M | 368.81M | 569.07M |
| Cash & Short-Term Investments | 35.92M | 59.86M | 220.41M | 215.74M | 239.76M | 207.75M | 410.43M | 290.23M | 355.18M | 537.03M |
| Cash Only | 35.92M | 59.86M | 179.57M | 164.43M | 197.61M | 163.08M | 241.44M | 147.75M | 205.05M | 293.29M |
| Short-Term Investments | 0 | 0 | 40.84M | 51.31M | 42.15M | 44.67M | 168.99M | 142.48M | 150.13M | 243.73M |
| Accounts Receivable | 10.93K | 1.23M | 3.78M | 4.86M | 2.65M | 1.75M | 6.67M | 4.7M | 3.98M | 4.71M |
| Days Sales Outstanding | 2.09 | 179.39 | 62.9 | 52.92 | 34.88 | 26.04 | 56.45 | 44.15 | 36.5 | 49.29 |
| Inventory | 0 | 12.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | 246.84 | - | - | - | - | - | - | - | - |
| Other Current Assets | 372.82K | 113.58K | 0 | 1.08M | 1.38M | 1.06M | 2.17M | 2.2M | 727K | 1.72M |
| Total Non-Current Assets | 1.07M | 1.25M | 10.4M | 26.18M | 16.01M | 13.22M | 32.42M | 70.1M | 86.68M | 213.62M |
| Property, Plant & Equipment | 355.32K | 681.5K | 1.4M | 2.77M | 8.93M | 8.02M | 7.28M | 24.84M | 23.5M | 20.02M |
| Fixed Asset Turnover | 5.36x | 3.68x | 15.64x | 12.10x | 3.11x | 3.06x | 5.92x | 1.56x | 1.69x | 1.74x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 475.59K | 393.34K | 374.31K | 2.8M | 2.88M | 2.84M | 2.35M | 1.95M | 1.8M | 1.68M |
| Long-Term Investments | 0 | 0 | 8.47M | 19.38M | 2.01M | 0 | 20.3M | 36.46M | 57.31M | 187.01M |
| Other Non-Current Assets | 238.34K | 175.63K | 154.76K | 1.23M | 1.91M | 1.95M | 2.08M | 4.81M | 2.87M | 953K |
| Total Assets | 38.81M | 76.05M | 236.11M | 249.96M | 263.38M | 231.22M | 456.6M | 376.54M | 455.49M | 785.13M |
| Asset Turnover | 0.05x | 0.03x | 0.09x | 0.13x | 0.11x | 0.11x | 0.09x | 0.10x | 0.09x | 0.04x |
| Asset Growth % | 8.01% | 0.96% | 2.1% | 0.06% | 0.05% | -0.12% | 0.97% | -0.18% | 0.21% | 0.72% |
| Total Current Liabilities | 6.91M | 8.15M | 22.46M | 33.14M | 36.79M | 46.75M | 71.9M | 78.93M | 69.09M | 87.08M |
| Accounts Payable | 2.42M | 2.3M | 3.43M | 3.24M | 3.03M | 3.13M | 13.24M | 9.83M | 4.6M | 4.16M |
| Days Payables Outstanding | 54.57 | 45.53 | 36.64 | 24.73 | 22.27 | 19.9 | 56.01 | 360.62 | 159.96 | 69.33 |
| Short-Term Debt | 182.58K | 175.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.7M |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 589.77K | 231.38K | 535.07K | 207.45K | 21K | 11K | 1.11M | 38K | 35K | 103K |
| Current Ratio | 5.46x | 9.17x | 10.05x | 6.75x | 6.72x | 4.66x | 5.90x | 3.88x | 5.34x | 6.54x |
| Quick Ratio | 5.46x | 7.64x | 10.05x | 6.75x | 6.72x | 4.66x | 5.90x | 3.88x | 5.34x | 6.54x |
| Cash Conversion Cycle | - | 380.71 | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 957.73K | 32.1M | 156.2M | 111.73M | 95.29M | 82.21M | 68.5M | 50.56M | 30.06M | 47.69M |
| Long-Term Debt | 531.34K | 335.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 3.87M | 2.52M | 2.26M | 11.79M | 10.49M | 8.21M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 1.11M | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | -1.11M | 0 | 0 | 0 | 0 |
| Total Liabilities | 7.86M | 40.26M | 178.65M | 144.87M | 132.08M | 128.95M | 140.4M | 129.49M | 99.15M | 134.77M |
| Total Debt | 713.93K | 511.13K | 0 | 0 | 5.25M | 3.95M | 3.75M | 13.47M | 12.16M | 9.91M |
| Net Debt | -35.2M | -59.35M | -179.57M | -164.43M | -192.36M | -159.13M | -237.68M | -134.28M | -192.88M | -283.38M |
| Debt / Equity | 0.02x | 0.01x | - | - | 0.04x | 0.04x | 0.01x | 0.05x | 0.03x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -108.40x | - | -154.87x | - | - | - | -612.81x | - | - | - |
| Total Equity | 30.94M | 35.79M | 57.45M | 105.09M | 131.3M | 102.26M | 316.2M | 247.06M | 356.34M | 647.93M |
| Equity Growth % | 8.15% | 0.16% | 0.61% | 0.83% | 0.25% | -0.22% | 2.09% | -0.22% | 0.44% | 0.82% |
| Book Value per Share | 2.01 | 2.71 | 2.99 | 4.72 | 5.42 | 3.50 | 8.18 | 5.50 | 6.91 | 10.09 |
| Total Shareholders' Equity | 30.94M | 35.79M | 57.45M | 105.09M | 131.3M | 102.26M | 316.2M | 247.06M | 356.34M | 647.93M |
| Common Stock | 847.31K | 1.52M | 2.1M | 2.37M | 2.92M | 3.21M | 4.48M | 4.75M | 5.88M | 6.96M |
| Retained Earnings | -69.3M | -112.84M | -200.93M | -259.45M | -314.6M | -400.11M | -466.93M | -598.12M | -753.06M | -968.39M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 1.59M | 9.07M | -9.22M | -30.45M | -22.53M | -55.47M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -25.18M | -27.06M | -44.88M | -46.33M | -63.05M | -79.9M | -59.63M | -149.9M | -142.21M | -185.84M |
| Operating CF Margin % | -13.22% | -10.78% | -2.05% | -1.38% | -2.27% | -3.26% | -1.38% | -3.86% | -3.57% | -5.33% |
| Operating CF Growth % | -0.42% | -0.07% | -0.66% | -0.03% | -0.36% | -0.27% | 0.25% | -1.51% | 0.05% | -0.31% |
| Net Income | -25.35M | -49.67M | -87.69M | -27.76M | -55.15M | -85.51M | -66.82M | -131.19M | -154.94M | -215.33M |
| Depreciation & Amortization | 211.01K | 246.1K | 381.5K | 729.81K | 1.14M | 1.44M | 1.49M | 1.28M | 2.54M | 2.47M |
| Stock-Based Compensation | 619.9K | 3.48M | 15.37M | 9.07M | 7.83M | 9.37M | 17.09M | 24.54M | 26.23M | 45.83M |
| Deferred Taxes | -213.19K | 20.53M | 31.63M | -7.07M | -89K | -122K | -7K | -1.62M | 842K | -321K |
| Other Non-Cash Items | 158.53K | -34.7K | -1.25M | -1.35M | -1.6M | 9M | -27.25M | -23.93M | 8.88M | -42.81M |
| Working Capital Changes | -608.97K | -1.62M | -3.33M | -19.94M | -15.18M | -14.08M | 15.87M | -18.97M | -25.75M | 24.32M |
| Change in Receivables | -892.13K | -1.44M | -2.2M | -2.95M | 633K | 1.15M | -4.99M | 1.83M | 1.73M | 1.07M |
| Change in Inventory | 516.04K | 181.94K | 6.23M | -743.54K | 2.29M | 4.13M | 0 | 0 | 0 | 0 |
| Change in Payables | 10.93K | -127.25K | 605.85K | 706.93K | 22K | -110K | 10.71M | -3.92M | -3.93M | -136K |
| Cash from Investing | -57.95K | -429.09K | -49.94M | -22.21M | 24.17M | -1.49M | -146.62M | 2.8M | -27.02M | -220.22M |
| Capital Expenditures | -112.61K | -521.64K | -868.58K | -4.21M | -2.6M | -1.29M | -870K | -7.64M | -3.98M | -1.67M |
| CapEx % of Revenue | 0.06% | 0.21% | 0.04% | 0.13% | 0.09% | 0.05% | 0.02% | 0.2% | 0.1% | 0.05% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 54.66K | 92.55K | 1.11M | 1.46M | -375K | -162.9K | 0 | -52K | -52K | -163K |
| Cash from Financing | 59.44M | 52.8M | 223.41M | 60.86M | 74.23M | 39.52M | 281.95M | 58.74M | 230.09M | 494.01M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | 60.13K | -188.25K | 134.33M | 0 | 48K | 1.45M | 16.85M | 999K | 4.14M | 36.53M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -25.29M | -27.59M | -45.75M | -50.53M | -65.65M | -81.19M | -60.5M | -157.54M | -146.19M | -187.5M |
| FCF Margin % | -13.28% | -10.99% | -2.09% | -1.51% | -2.37% | -3.31% | -1.4% | -4.06% | -3.67% | -5.38% |
| FCF Growth % | -0.41% | -0.09% | -0.66% | -0.1% | -0.3% | -0.24% | 0.25% | -1.6% | 0.07% | -0.28% |
| FCF per Share | -1.64 | -2.09 | -2.38 | -2.27 | -2.71 | -2.78 | -1.57 | -3.51 | -2.83 | -2.92 |
| FCF Conversion (FCF/Net Income) | 1.08x | 0.57x | 0.69x | 1.87x | 1.28x | 1.14x | 1.02x | 1.22x | 1.01x | 0.89x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 320K | 322K | 635K | 0 | 3.1M | 2.8M |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -174.76% | -142.17% | -138.94% | -30.41% | -41.6% | -59.94% | -28.06% | -43.5% | -46.52% | -41.39% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | - | -547.69% | -117.19% | -77% | -74.61% |
| Gross Margin | -749.4% | -634.02% | -55.72% | -42.7% | -78.85% | -133.91% | -99.94% | 74.37% | 73.62% | 37.15% |
| Net Margin | -1220.79% | -1889.92% | -295.57% | -73.77% | -177.15% | -285.59% | -136.06% | -315.48% | -352.56% | -595.93% |
| Debt / Equity | 0.02x | 0.01x | - | - | 0.04x | 0.04x | 0.01x | 0.05x | 0.03x | 0.02x |
| Interest Coverage | -108.40x | - | -154.87x | - | - | - | -612.81x | - | - | - |
| FCF Conversion | 1.08x | 0.57x | 0.69x | 1.87x | 1.28x | 1.14x | 1.02x | 1.22x | 1.01x | 0.89x |
| Revenue Growth | 46.2% | 31.76% | 773.11% | 52.86% | -17.15% | -11.69% | 76.02% | -9.99% | 2.5% | -12.38% |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Collaboration Revenue | - | 5.52M | 3.36M | 19.5M | 41.59M | 43.95M | 36.13M |
| Collaboration Revenue Growth | - | - | -39.04% | 479.93% | 113.23% | 5.68% | -17.78% |
| Collaboration Revenue Related Party | - | 25.83M | 26.58M | 29.6M | - | - | - |
| Collaboration Revenue Related Party Growth | - | - | 2.90% | 11.38% | - | - | - |
| Grant Revenue | - | -215K | - | - | - | - | - |
| Grant Revenue Growth | - | - | - | - | - | - | - |
| Upfront and Milestone Payments | 900K | - | - | - | - | - | - |
| Upfront and Milestone Payments Growth | - | - | - | - | - | - | - |
Merus N.V. (MRUS) reported $51.2M in revenue for fiscal year 2024. This represents a 9071% increase from $0.6M in 2013.
Merus N.V. (MRUS) saw revenue decline by 12.4% over the past year.
Merus N.V. (MRUS) reported a net loss of $334.9M for fiscal year 2024.
Merus N.V. (MRUS) has a return on equity (ROE) of -41.4%. Negative ROE indicates the company is unprofitable.
Merus N.V. (MRUS) had negative free cash flow of $317.9M in fiscal year 2024, likely due to heavy capital investments.